Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Liviu Klein*, Barry M. Massie, Jeffrey D. Leimberger, Christopher M. O'Connor, Ileana L. Piña, Kirkwood F. Adams, Robert M. Califf, Mihai Gheorghiade, Investigators OPTIME-CHF Investigators
Dive into the research topics of 'Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).'. Together they form a unique fingerprint.